<?xml version='1.0' encoding='UTF-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta id="journal-meta-8795060ee5324fbeb0aa484501471146">
      <journal-id journal-id-type="nlm-ta">Prathima Institute of Medical Sciences</journal-id>
      <journal-id journal-id-type="publisher-id">Prathima Institute of Medical Sciences</journal-id>
      <journal-id journal-id-type="journal_submission_guidelines">https://www.pimr.org.in/instructions.php</journal-id>
      <journal-title-group>
        <journal-title>Perspectives in Medical Research</journal-title>
      </journal-title-group>
      <issn publication-format="electronic">2348-229X</issn>
      <issn publication-format="print">2348-1447</issn>
    </journal-meta>
    <article-meta id="article-meta-a3de3e21fb2644548175d8759b086b27">
      <article-id pub-id-type="doi">10.47799/pimr.1301.08</article-id>
      <article-categories>
        <subj-group>
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title id="article-title-9d011f4461d54dcebfa2940ea2a78373">Evaluating Field Stain for Rapid On-Site Evaluation in Fine Needle Aspiration Cytology of Breast Lesions: Diagnostic Utility with May-Grünwald Giemsa Staining</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name id="name-307bbc79af1543638020e5751b9571d5">
            <surname>Galat</surname>
            <given-names>Swapnil</given-names>
          </name>
          <email>swapnilgalat@gmail.com</email>
          <xref id="x-cec187d09696" rid="a-c261e9bc6f24" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-e7f0c2c57b7a471698507ca816d41888">
            <surname>Nayak</surname>
            <given-names>Supreeta</given-names>
          </name>
          <xref id="x-3922fd85c74b" rid="a-add7009e231f" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-9c2068d240874dcd8c0520e2e6c8e4df">
            <surname>Tadvi</surname>
            <given-names>Farheen</given-names>
          </name>
          <xref id="x-0c5364e04ba9" rid="a-c261e9bc6f24" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-62943d2af1914e6097af85b73892223b">
            <surname>Yedshikar</surname>
            <given-names>Vikas</given-names>
          </name>
          <xref id="x-320bf180cf4b" rid="a-9689e1927a2c" ref-type="aff">3</xref>
        </contrib>
        <aff id="a-c261e9bc6f24">
          <institution>Assistant Professor, Department of Pathology, Shri Vasantrao Naik Government Medical College</institution>
          <addr-line>Yavatmal, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="a-add7009e231f">
          <institution>Associate Professor, Department of Pathology, Government Medical College</institution>
          <addr-line>Nagpur, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="a-9689e1927a2c">
          <institution>Professor and Head, Department of Pathology, Shri Vasantrao Naik Government Medical College</institution>
          <addr-line>Yavatmal, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
      </contrib-group>
      <volume>13</volume>
      <issue>1</issue>
      <fpage>35</fpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>3</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>4</month>
          <year>2025</year>
        </date>
        <date date-type="rev-recd">
          <day>15</day>
          <month>3</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©2025 (Galat) et al. This is an open-access journal, and articles are distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.</copyright-statement>
        <copyright-year>2025</copyright-year>
      </permissions>
      <abstract id="abstract-abstract-title-4991dc140fbf44aea54efe83aa905915">
        <title id="abstract-title-4991dc140fbf44aea54efe83aa905915">Abstract</title>
        <p id="paragraph-f04ab7504008409b8004e299c2678e6e"><bold id="strong-b472d68358114fae97f608728a6fd3e3">Introduction:</bold> Fine Needle Aspiration (FNA) cytology is a well-established essential, basic diagnostic technique for investigating lumps and lesions at various anatomic sites. While performing FNA of the breast lumps a quick or rapid result is desirable to know the nature of the lump and allay the anxiety of the patient. Rapid On-Site Evaluation (ROSE) is useful to evaluate the cytological smears within a few minutes. This study aims to evaluate the utility of Field’s stain in ROSE of breast lesions in arriving at a diagnosis and its comparison to routine MGG ( May Grünwald Giemsa) stain. <bold id="strong-5eddf814e2fb43ff9c69091c7622bfbc">Materials and methods:</bold> This prospective observational study was conducted from July 2023 to December 2023 at a tertiary care center. A total of 89 cases with breast lumps were included. Previously diagnosed cases were excluded. All the cases were evaluated by ROSE using Field’s stain for preliminary diagnosis and compared later with MGG stain for final diagnosis. The categorization of cases was done as per IAC Yokohama System and further management was advised accordingly. <bold id="strong-73ce85b378b247088de862dfc404ada2">Results:</bold> After first and repeat aspiration 62 (69.6%) cases were categorized as benign, 12 (13.4%) cases were found to be malignant whereas 8 (8.9%), 5 (5.6%), 2 (2.24%) cases were included in the suspicious, atypical and insufficient categories respectively. Categorization of the breast lumps by ROSE using Field stain was in complete agreement with the MGG stained smears and the final FNA diagnosis and showed no discrepancy. <bold id="strong-559d9ba3efa9442594da29bd49728293">Conclusion:</bold> The use of Field’s stain for ROSE of breast lumps had comparable staining quality to MGG which resulted in accurate correlation between provisional and final cytologic diagnoses with the added advantage of rapid turnaround time. Field stain was hence found to be reliable, cost effective and time saving when used for ROSE of breast lumps. Hence the use of this readily available and affordable stain for ROSE of FNA smears, especially of breast lumps, can prove to be highly beneficial for prompt categorization and triaging of patients.</p>
      </abstract>
      <kwd-group id="kwd-group-aef6160045fc4ba6acc476c78f636c01">
        <title>Keywords</title>
        <kwd>Rapid on site evaluation</kwd>
        <kwd>Breast</kwd>
        <kwd>Field Stain</kwd>
        <kwd>Prompt Categorization</kwd>
        <kwd>Triage</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title id="title-1efb6473851e4da59da4e1a589c749a9">INTRODUCTION</title>
      <p id="paragraph-e5146645d91b4f8390734a01d0f8fda0">Fine needle aspiration cytology is a well-established essential, basic diagnostic technique for investigating lesions at various anatomic sites. It is a relatively safe, accurate procedure with a low complication rate. It has high sensitivity and specificity in the diagnosis of malignant lesions.<sup id="superscript-c020ec224f664d58ad912b713a9c35ce"><xref id="xref-08fce8f486a2426d89625ccf29169bb4" rid="R271324933257364" ref-type="bibr">1</xref></sup> Stains commonly used for staining FNA smears are Hematoxylin &amp; Eosin (H&amp;E), Papanicoloau, and Giemsa. The whole procedure takes 2-3 hours to complete. If the sample is adequate and representative it will lead to a correct diagnosis, but inadequate, non-representative will lead to repeat procedure causing delay in diagnosis, wastage of time and resources which increases the anxiety to patients.<sup id="superscript-5e730d6731ee445095ee5d44100bb6cb"><xref id="xref-9185790f92f146dc88081578199e0537" rid="R271324933257369" ref-type="bibr">2</xref></sup> To minimize these complications, the demand for Rapid On-Site Evaluation (ROSE) has increased in cytopathology laboratories. Rapid on-site evaluation (ROSE) is a procedure that allows assessment of adequacy of cytological specimens generally obtained by needle aspiration techniques.<sup id="superscript-9aac28badec44af3acfa40497c6c3db9"><xref rid="R271324933257373" ref-type="bibr">3</xref>, <xref rid="R271324933257367" ref-type="bibr">4</xref></sup> Using a quick staining method, it is possible to have a smeared cytological slide ready to be evaluated using light microscopy, within few minutes.<sup id="s-af0a1d7a1371"><xref id="xref-278520c1d8254aca8ceffa6708e997be" rid="R271324933257360" ref-type="bibr">5</xref></sup> It is an immediate, real-time evaluation of fine-needle aspiration smears and biopsy touch imprints. It is highly advantageous adjunct to any routine diagnostic method using fine-needle aspiration (FNA), useful for assessment of lesions or masses from deep-seated organs. Samples obtained by ROSE can be used for diagnosis based on morphologic criteria alone and also for special ancillary studies, including molecular analysis. It is an effective way for morphological analysis of samples, ensuring sufficient quantities and quality of cells for complete diagnostic workup. The reported rate of non-diagnostic (ND) FNA is as high as 20%.<sup id="superscript-c440e1db6b73401cb7b0b0b57c94beb0"><xref id="xref-faaedc238f92452db7e2871794d55363" rid="R271324933257366" ref-type="bibr">6</xref></sup> Several studies concluded that ROSE resulted in a significant decrease in the number of non-diagnostic cases. ROSE has various advantages like reduced additional sampling and turnaround-time, cost-effective with improvement in diagnostic yield.<sup id="superscript-e34f62bd2f97461b9ed8cebebca5b08f"><xref id="xref-5156e49fee8343adb712efdbeac34a86" rid="R271324933257359" ref-type="bibr">7</xref></sup> </p>
      <p id="paragraph-19b6378ea13b499a9be128bf99d30150">ROSE performing laboratories commonly use a variety of quick stains like Wright-Giemsa, Diff-Quick, Papanicolaou, which are costly. Stains like Toluidine Blue are cheaper but stains only the nucleus due to which cell morphology cannot be appreciated. Field stain is a Romanowasky’s stain, which comprises Field stain A and B. Composition of Field stain A is methylene blue, azur, disodium dihydrogen phosphate anhydrous, potassium dihydrogen phosphate anhydrous and distilled water. Composition of field stain B is eosin powder, disodium dihydrogen phosphate anhydrous, potassium dihydrogen phosphate anhydrous and distilled water. Some studies have concluded that Field’s stain has staining quality comparable to conventional Giemsa stain for both qualitative and quantitative analysis. This stain is used as a quick staining method for detection of malaria and filaria parasites in screening camps.<sup id="superscript-345f170e2c994bc48ba18c9ed08b4a8b"><xref id="xref-260109593f1a45a5bce3521e306543af" rid="R271324933257358" ref-type="bibr">8</xref></sup> The advantages of Field stain are rapid staining time, only 2 reagents with 70% alcohol as a fixative are required, inexpensive, high reproducibility, good correlation with histological diagnosis, helpful for detection of blood parasites and fungi.<sup id="s-00b4d9f4dec1"><xref id="xref-f75756ec63324b179bc6a2ac348b29c0" rid="R271324933257372" ref-type="bibr">9</xref></sup> However, this stain has few limitations like not being ideal for thin smears, limited cellular details and potential for overstaining.<sup id="superscript-da3b462f645c4bcb8c64e24197466690"><xref id="xref-751e5a4e7c5346d5aded3183711db0bb" rid="R271324933257358" ref-type="bibr">8</xref></sup> </p>
      <sec>
        <title id="t-cd733bfc246e">
          <bold id="strong-9d752ea69c9d4db5a908dca2c921af6f">Aims and Objectives</bold>
        </title>
        <list list-type="bullet">
          <list-item id="li-40208d073718">
            <p>To evaluate the utility of Field Stain in ROSE in arriving at a diagnosis in comparison to routine stains (MGG).</p>
          </list-item>
          <list-item id="li-31cb8f694f4c">
            <p>Screening for adequacy of FNA smears of breast lumps using Field’s stain.</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec>
      <title id="title-cf5bb6e4a8ae476dad580de2d9e03806">MATERIALS AND METHODS</title>
      <p id="p-a7f82cadb299"><bold id="strong-4f4c85c369894152b4c921ae0d5c7b00">Study Design: </bold>This was prospective observational study. </p>
      <p id="p-d7a63d6a0a72"><bold id="strong-ff5738b25d3247d6b4dd3f6d77a3bfdc">Source of data: </bold>Data from patients presented with breast lump in the cytology outpatient clinic was collected. </p>
      <p id="p-053872efd203"><bold id="strong-5b52fa7acfc74032b49d440faa77eb45">Study duration and location:</bold> This study was conducted between July 2023 to December 2023 in the Department of Pathology at tertiary care center. </p>
      <p id="p-be6f8290b9f3"><bold id="strong-55ea9821bddb4525b02b319052b2f813">Sample size:</bold> A total of 89 cases were included in this study.</p>
      <p id="p-08af4ad394f7"><bold id="strong-9c7bf146ae9e4d419a893a3fb504c68c">Inclusion criteria:</bold> Patients presented with breast lump for the first time were included. </p>
      <p id="p-51d8be1d7d3d"><bold id="strong-c2ffb8656ae0429d86e7405fd0d41467">Exclusion criteria:</bold> Already diagnosed cases were excluded.</p>
      <p id="p-046e7010fa30"><bold id="strong-b38b4fdc29cf4dd186617a6dc5dc70dd">Procedure and Methodology:</bold> Detailed clinical history was taken along with findings of radiological and previous laboratory reports. Thorough physical examination of patients was done. Non-guided FNA and whenever required ultrasound- guided FNA was performed without local anesthesia using 23G needle, 10 ml syringe and aspiration gun. The aspirated material was spread on slides to make smears. One smear for ROSE was fixed in absolute alcohol or methanol and air dried rapidly. The fixed smear was then dipped in Field stain B 15 times and washed in water. Then the smear was dipped in Field stain A 20 times, washed in water and air dried. The Field stained smear was evaluated for ROSE to make a preliminary diagnosis. The other air dried smears were stained with MGG stain as per routine procedure for final diagnosis. The evaluation was not blinded as clinical examination and radiological investigations like ultrasonography were necessary for correlation. The multiple observers were involved with no interobserver variability in arriving at a preliminary diagnosis. </p>
      <p id="paragraph-c4a9874db3704bb5986058e32ca9b447">The reporting was carried out using IAC Yokohama System for Reporting Breast FNA Cytopathology to make a preliminary diagnosis. The criteria adopted for adequacy of smears was seven epithelial groups each consisting of 20 or more epithelial cells along with presence or absence of myoepithelial cells<sup id="superscript-7d4233ce5472416098f492849cc65bc7"><xref id="xref-387dec9f871c40b8947e8472a5ecae90" rid="R271324933257357" ref-type="bibr">10</xref></sup>. If fewer than 7 epithelial groups found smears were labelled as scanty cellular while smears with more than 10 epithelial groups were labelled as highly cellular.</p>
      <p id="paragraph-3241a283a72f4911ae025afedab1fca4">In those cases where initial FNA yielded scanty cellularity, repeat FNA was immediately done, and smear was stained using Field stain and ROSE revaluation was again done. Smears stained with Field Stain were later compared with MGG stained smears. The features that were compared included cell morphology, background, stroma and any other additional features. Preliminary diagnosis on ROSE was also compared with final specific cytopathology diagnosis that was offered on MGG.</p>
      <p id="p-b572b36569f8"><bold id="strong-193cb982f35944938beffd557c06c5eb">Statistical Methods: </bold>Data were analyzed using the SPSS software version 22.0. Descriptive statistics such as means and standard deviations were used to summarize continuous variables, and frequencies and percentages were used for categorical variables. Kappa statistics was used to measure the level of agreement. Sensitivity, specificity, positive predictive value, negative predictive values were calculated.</p>
    </sec>
    <sec>
      <title id="t-029b854490b9">
        <bold id="strong-407804afbb2c425f86262952a53abaf3">OBSERVATIONS AND RESULTS</bold>
      </title>
      <p id="paragraph-5280cf406e1042e0ae294ca3068d819b">A total of 89 cases presented with breast lump were included in this study. Majority of cases were in the age group of 11 to 20 years (26.96%) followed by 21 to 30 years age group (25.84%). The age range was 15 years to 86 years and mean age (±SD) was 32.93 (±8.48) years. There were 3 males while the remaining 86 were females. <xref id="x-3be2d778a3c9" rid="table-wrap-40b8b5ca14de4eafa230ead7d838d79e" ref-type="table">Table 1</xref> shows age-wise distribution of cases.</p>
      <table-wrap id="table-wrap-40b8b5ca14de4eafa230ead7d838d79e" orientation="portrait">
        <label>Table 1</label>
        <caption id="caption-9e8be83dbcf6447290b983bda0f8b0dc">
          <title id="title-728a81199cde42089cdb820a5db53ba3">
            <bold id="strong-a63304f5c24f4cca81890d59c457710e">Age-wise distribution of cases with breast lumps</bold>
          </title>
        </caption>
        <table id="table-25311a8c3f6e4843840ffef994a86c7c" rules="rows">
          <colgroup>
            <col width="37.330000000000005"/>
            <col width="35.77"/>
            <col width="26.899999999999995"/>
          </colgroup>
          <tbody id="table-section-276d87fa23c7417ea4173d0f6d6addaa">
            <tr id="table-row-6e725bf0238940be81da4b6745111f1f">
              <td id="table-cell-00ab50336e8a4209bf4e0ceab208d455" align="left">
                <p id="paragraph-54def2f8a0534b7eaa16c3050eaa25ca"> <bold id="strong-8ac05e438ec34f4981618fc045577299">Age Group </bold></p>
                <p id="p-6c1f3154cbed">
                  <bold id="s-809f135bc5ec">(years)</bold>
                </p>
              </td>
              <td id="table-cell-9f61c0d100484bb4bb0f85783b0d03ee" align="left">
                <p id="paragraph-fbd5f7682c3c48098bcf819b790b7f13"> <bold id="strong-fe6033a287544968b82daa54782faaec">Number of cases</bold></p>
              </td>
              <td id="table-cell-dec9c7093cba48a897f9c3144ba2bd84" align="left">
                <p id="paragraph-4111b6a89dbe4dd8a239f8712575ca88">
                  <bold id="strong-84233ed70f684d4aa2e01b4ee674cd2b">Percentage</bold>
                </p>
              </td>
            </tr>
            <tr id="table-row-ce4d8eec62ff4992bfd71a3df894411c">
              <td id="table-cell-5d71c530f8c1471fb186f70dfb11ee5d" align="left">
                <p id="paragraph-2957edb5820c41b888595f55b88e84ff"> 11-20</p>
              </td>
              <td id="table-cell-e9332e1a0a4b41fc8d280614ab170b87" align="left">
                <p id="paragraph-b9bb3db188e24c4fa68d11d468df3649"> 24</p>
              </td>
              <td id="table-cell-f16aca390ba44fdfba9323a415e09e3a" align="left">
                <p id="paragraph-cb4808eb62de477f97023657e08b1ec1"> 26.96%</p>
              </td>
            </tr>
            <tr id="table-row-7137f0d75af44988bf5c06b9900b31bf">
              <td id="table-cell-15c16e0d08a9489a9a198077fa17db33" align="left">
                <p id="paragraph-7a9d0f93e56945db8eb7835b7834f2cb"> 21-30</p>
              </td>
              <td id="table-cell-f3b8c39dee9e4c2db751cadf09205603" align="left">
                <p id="paragraph-42a00e5d56bd4bb3b634388e83f91951"> 23</p>
              </td>
              <td id="table-cell-a1266703af78485bb8db86c49d0ba6a6" align="left">
                <p id="paragraph-925f6b3596344c89805fcb032ab93b58"> 25.84%</p>
              </td>
            </tr>
            <tr id="table-row-dc8706ef52dd413f95735bc2ec716167">
              <td id="table-cell-b04de53c0b01410283d76f93894acbef" align="left">
                <p id="paragraph-77148c202b054825946d5146d15992bb"> 31-40</p>
              </td>
              <td id="table-cell-0bd3eba91c5e42f49194822d5c9eaa67" align="left">
                <p id="paragraph-d898d00014354036b8808c0e61621d34"> 17</p>
              </td>
              <td id="table-cell-50bc6a2a7c1046ad87f6eb45c54c06c5" align="left">
                <p id="paragraph-2b522bd6e8d6499b9e0f1468368ab528"> 19.10%</p>
              </td>
            </tr>
            <tr id="table-row-fa0e21216c484686aac02d5fedbd9c45">
              <td id="table-cell-0185e54b786847c989192f0c80696523" align="left">
                <p id="paragraph-cca4782246e748d9b3f683c183f6c887"> 41-50</p>
              </td>
              <td id="table-cell-db04abee46984bc8a50d5eb7a0960c76" align="left">
                <p id="paragraph-6b128efe70104584bbbf2d435715148d"> 12</p>
              </td>
              <td id="table-cell-aa6dd4877404426694b0c519afaba318" align="left">
                <p id="paragraph-bb1567ebe88446b68dee757b71c2b318"> 13.48%</p>
              </td>
            </tr>
            <tr id="table-row-8b63e5ad5f7a48e58a3182f57f26e212">
              <td id="table-cell-a8238d501fbc4e3783b92f9e007cd5a3" align="left">
                <p id="paragraph-379e0eb39c2d44cd88c281d8a6a0db1e"> 51-60</p>
              </td>
              <td id="table-cell-7cb1f9209fed4c918b7f4d2234ceb5e7" align="left">
                <p id="paragraph-9aaad803a209499fbd77c9cb4324d0ef"> 10</p>
              </td>
              <td id="table-cell-ff14932e579b43f29307fb8a597b0165" align="left">
                <p id="paragraph-ced0429ad01d4a4ca3c6235463d04bfa"> 11.23%</p>
              </td>
            </tr>
            <tr id="table-row-f81e9ffa1dc644ed827413e1df4daf92">
              <td id="table-cell-607123fe8f6f44c588cf54832c1b2492" align="left">
                <p id="paragraph-98604b67f820499897fa1a1ee7c9766c"> &gt;61</p>
              </td>
              <td id="table-cell-e99620ecb2f7417aa35814ab6459618e" align="left">
                <p id="paragraph-79803a414e82466ba328c4da1d461d6d"> 3</p>
              </td>
              <td id="table-cell-51a87ee1105a4df9982935611e964370" align="left">
                <p id="paragraph-ed9964c3050c49cd8c43cecfde1102ac"> 3.37%</p>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p id="paragraph-137eb18a1200412f97f7f2b77e042590">After the first attempt of FNA, all cases were evaluated and categorized as per Yokohama system. ROSE of Field stained smears revealed scant cellularity in 12 cases, while moderate cellularity and high cellularity were observed in 46 and 29 cases respectively. So, a total of 12 cases were categorized as Insufficient after ROSE of the first FNA. Repeat FNA was done immediately in these 12 cases. Of these 12 cases, ROSE revealed that repeat FNA yielded cellular smears in 10 cases which were re-categorized as per Yokohama system, while scant cellularity was again obtained in 2 cases that were included in the Insufficient category and biopsy was advised. </p>
      <p id="paragraph-0c0771d094a744908584610363a41fce">62 (69.6%) cases were categorized as benign that included 54 benign cases after first aspiration and 8 cases after immediate repeat aspiration that had initially been categorized as insufficient. 12 (13.4%) cases were found to be malignant after ROSE of which 11 cases were categorized as malignant after first aspiration and 1 case after repeat aspiration. 8 (8.9%) cases were included in the suspicious category which included 1 case after repeat aspiration and 5 (5.6%) cases were in atypical category. </p>
      <p id="p-b06d1deed55e"><xref id="x-6ba114cd796c" rid="table-wrap-28b6d404ce064bd8becd1e8bf3ecd534" ref-type="table">Table 2</xref>  shows categorization of cases as per Yokohama system after ROSE.</p>
      <table-wrap id="table-wrap-28b6d404ce064bd8becd1e8bf3ecd534" orientation="portrait">
        <label>Table 2</label>
        <caption id="caption-63b5c44cc2704920b04acae51792969c">
          <title id="title-9e5ba26112904a4180f6facdb01240b6">
            <bold id="strong-6b13040d68f44d4ba3ca9449d3f9578c">Categorization of cases as per Yokohama system after ROSE using Field’s stain and Final FNA report using MGG stain</bold>
          </title>
        </caption>
        <table id="table-87656b84010943608223422cd86be45b" rules="rows">
          <colgroup>
            <col width="13.740000000000002"/>
            <col width="12.5"/>
            <col width="13.940000000000001"/>
            <col width="23.200000000000003"/>
            <col width="16.21"/>
            <col width="20.409999999999997"/>
          </colgroup>
          <tbody id="table-section-02a6290c9f8a47fd80732ef125a3d392">
            <tr id="table-row-8fc9d771caa7461d86bb021d12f5ee50">
              <td id="table-cell-fba2aae2298f45069021a16eaec9251c" rowspan="2" align="left">
                <p id="paragraph-60f943e5497d476aaed6ef8f6f6f75b2"> <bold id="strong-15352f5319b04bbba05404a8e451daa1">Categories</bold> </p>
              </td>
              <td id="table-cell-b2a12774c6dd4dc8a7febc34361e9c7b" colspan="2" align="center">
                <p id="paragraph-b09cbbd470d34b02a1af5aa14e9d6236"> <bold id="strong-5b1480f3fbe84e689250b5c67def1ca1">ROSE (Field stain)</bold></p>
              </td>
              <td id="table-cell-d8a7bf74835e4616a6eddb109505621c" rowspan="2" align="left">
                <p id="paragraph-fc0ddec1b0f549d594e808add2d25247"> <bold id="strong-91fa9165550c4f7b9ad64b0c96c265fb">Management</bold> <bold id="strong-93d624ec49e3406e9a13f19a4023e0c5">(As per ROSE)</bold></p>
              </td>
              <td id="table-cell-2110b80bb766488d87e3997b51952480" rowspan="2" align="left">
                <p id="paragraph-1973565d9a2a44cba8768da3250a9545"> <bold id="strong-034972e88df54ccc8aa97e10f1d6807f">Final FNA Report (MGG)</bold></p>
              </td>
              <td id="table-cell-61edefd774b8457898cb77415efb6f91" rowspan="2" align="left">
                <p id="paragraph-83e5ac6c941646e2a547c2f2c00a5527"> <bold id="strong-e8d674cb481c4fe0bb57c55edbf6dc6b">Management</bold> <bold id="strong-f7c76f63cdba4aa095c7d8786ded37eb">(As per Yokohama System)</bold></p>
              </td>
            </tr>
            <tr id="table-row-5b81cc2d63584b6d92ea47c3d78ab0e8">
              <td id="table-cell-89d18064d8e04d30a776c5aa1f7a0f62" align="left">
                <p id="paragraph-063425094f864052803380f725013957"> <bold id="strong-d7fcaa5d230e45f7b8e95e9ebc935e31">1</bold><bold id="strong-dc8d52ebc5ad443196861f824a25263e"><sup id="superscript-d1cadfd307df4afca3f4f3316acdc031">st</sup></bold><bold id="strong-85d09d4ce6174c9388e9c4b94efc34c8"> FNA</bold></p>
              </td>
              <td id="table-cell-21397d76a73a4609ba949a2825b58eeb" align="left">
                <p id="paragraph-440f213e76844dac8a98ea4d49f26a8b"> <bold id="strong-3d79904a622040baa84f37ba02bf3bc8">Repeat </bold> <bold id="strong-368fceb4e8e4440692ae3e03b7e3c6b5">FNA*</bold></p>
              </td>
            </tr>
            <tr id="table-row-c538414a0b494d48a00b98b14bd5e3a8">
              <td id="table-cell-7b5ec10432544af6be5296618a3208d1" align="left">
                <p id="paragraph-7483462cda074d5a8e99c20b7b18899e"> <bold id="strong-07ed678f917c48e880a945fa95488c8b">Insufficient</bold></p>
              </td>
              <td id="table-cell-d09f2b8d8ec64b0bad5f3b0c9c495102" align="left">
                <p id="paragraph-4f37db3d7928421bb6dcb4aeaa1b4538"> 12 (13.48%)</p>
              </td>
              <td id="table-cell-0ebdaafebe8b465588ff7cda958354e8" align="left">
                <p id="paragraph-0ab87d24501242b487a1f2f425dfae91"> 2 (2.24%)</p>
              </td>
              <td id="table-cell-9e01c7da723f418b92f2efa6a3338651" align="left">
                <p id="paragraph-7d6e40ff5f9044ffabe1b5989d7ba377"> Repeat FNA (after 1<sup id="superscript-737589fe87c74b52923a1cbae8357933">st</sup>) CNB (after repeat FNA)</p>
              </td>
              <td id="table-cell-6356bbd886174c8e9c8f38541fb37ba7" align="left">
                <p id="paragraph-f2ed8cb28c7c41b9806c7a4b5a0035b8"> 2 </p>
              </td>
              <td id="table-cell-08e81a80beae4d5abc95023881ad6348" align="left">
                <p id="paragraph-1734dc69e35d4c61b76ca86fcc6b9683"> Repeat FNA or  Core Needle Biopsy</p>
              </td>
            </tr>
            <tr id="table-row-92924280207243a8bf5e8c43c3be33c9">
              <td id="table-cell-6c63705eddf04356bfaeeabbdcf08ee1" align="left">
                <p id="paragraph-91e11d5c67784655851ff54d2ff55e16"> <bold id="strong-81a46f6f7bb9494f9fc655dbb57428ca">Benign</bold></p>
              </td>
              <td id="table-cell-af063598fc3347fbb7efe3e759ed1ec8" align="left">
                <p id="paragraph-741058e3769e468d8f1b97109a201bd2"> 54 (60.67%) </p>
              </td>
              <td id="table-cell-84aafd61802c4b6da8931e0b2e85923f" align="left">
                <p id="paragraph-1bee23d1f2894d3e96ee3db0d68c01c9"> 62 (69.66%)</p>
              </td>
              <td id="table-cell-176844ba2bd34cfaa21153323e03942e" align="left">
                <p id="paragraph-b03f890267bb49e187a16b792759479b"> Reassurance &amp; further management pre-planned </p>
              </td>
              <td id="table-cell-8a8b6efea35e404da78f7ddd0886164f" align="left">
                <p id="paragraph-bbbb82d88dfd4de2a617152ded41febc"> 62</p>
              </td>
              <td id="table-cell-75be6c21bc214840ae7f10c577abd449" align="left">
                <p id="paragraph-2ec7acadf2d940eaa6fa745b793133c9"> Follow up after 6 months/Surgical intervention</p>
              </td>
            </tr>
            <tr id="table-row-24345cc023e54becb1f7137b8a9f5083">
              <td id="table-cell-4ad01b1fefe84e3a8f2b0767df24304e" align="left">
                <p id="paragraph-f9de5686e05b4a798d6230f9ba994b79"> <bold id="strong-c18c6dd6a8db4a9c9320021b3c8cb703">Atypical</bold></p>
              </td>
              <td id="table-cell-5655eeb3bce94439990d45d50f811329" align="left">
                <p id="paragraph-cf75f76931574ecfbaee7d16a3c87fe9"> 5 (5.61%)</p>
              </td>
              <td id="table-cell-20f1ea4d9ac04433987f1474188a5ae9" align="left">
                <p id="paragraph-7c2eafc369064ab6b52d267a0190f718"> --</p>
              </td>
              <td id="table-cell-dd7db6d2461d470cbc63c30038fa0e78" align="left">
                <p id="paragraph-b9b2463c9e904fb69187b3ed51cf6d7b"> Follow up &amp; wait for Final FNA report</p>
              </td>
              <td id="table-cell-41914411fe334584bdd2bb7f958365c6" align="left">
                <p id="paragraph-b29be8cccbe841f6a3eb4c8ae38dba26"> 5</p>
              </td>
              <td id="table-cell-9b5bad4ad0ea44bfb779572f88e734ed" align="left">
                <p id="paragraph-2258b5bb5fc641b0b729033537e95f71"> Follow up with repeat FNA/ Advice for CNB</p>
              </td>
            </tr>
            <tr id="table-row-acf273aac12e4933a93da813bd24167f">
              <td id="table-cell-a8d698a6cb5d4057b4b05261f1e31d5c" align="left">
                <p id="paragraph-8d376bf11452423e9694f67ff4c42e3d"> <bold id="strong-235224bd9f0641f79117a9fd6e144d03">Suspicious</bold></p>
              </td>
              <td id="table-cell-c1c8d850cd4c48a490d4499364c07bdc" align="left">
                <p id="paragraph-0195d8fe513e48c0a190292568646ba7"> 7 (7.86%)</p>
              </td>
              <td id="table-cell-3eb1d6ae30ad4eca8468389f22fbf464" align="left">
                <p id="paragraph-6f357c58bd544e5783b9ab520a0cb0da"> 8 (8.98%)</p>
              </td>
              <td id="table-cell-963822a1a1c34d4a9fff8c0e38dbecf4" align="left">
                <p id="paragraph-f6a25c26bb774e6fb76a5d72aa2e7f6c"> Wait for Final FNA report</p>
              </td>
              <td id="table-cell-fe8b44dbeb1d400990beec2274e95d50" align="left">
                <p id="paragraph-b1ad5ae4075e403eb6397752ed27a3c2"> 8</p>
              </td>
              <td id="table-cell-c48d5b88cc5d4c9c8ca8f728f6fc48c3" align="left">
                <p id="paragraph-b3231ae5987b47cd8e075fdc6aa8ab24"> Advice for CNB/Immediate surgical intervention</p>
              </td>
            </tr>
            <tr id="table-row-005d86bffe1b40909f3d8b2dd7eb8699">
              <td id="table-cell-1c597a11ea77478ca4bbf115bbf11273" align="left">
                <p id="paragraph-a463375ff3a347b7883d15e0e302220f"> <bold id="strong-522fe45766a948b19ed81ea90ed8b8e1">Malignant</bold></p>
              </td>
              <td id="table-cell-49ec713f026a4cea8eece588cf273fc4" align="left">
                <p id="paragraph-394d373fa5124891bec9908eca5733a6"> 11 (12.35%)</p>
              </td>
              <td id="table-cell-7cf733fe5efa42e986dacd3ed17f4880" align="left">
                <p id="paragraph-a1c9c181c988479a847f9ef9d43fd081"> 12 (13.48%)</p>
              </td>
              <td id="table-cell-4196785ca59044248e3421b4303f5cbc" align="left">
                <p id="paragraph-687f4afd07cb4c98a55b096ddc09eb8e"> Immediate surgical opinion</p>
              </td>
              <td id="table-cell-4fc56d39fe07482c8b5e87e7aa4ab2d6" align="left">
                <p id="paragraph-b23429520ae043f9a920459542b2e558"> 12</p>
              </td>
              <td id="table-cell-cb618e00821a4414a20ed26348d287f9" align="left">
                <p id="paragraph-bdeedee7246d44cc9790cb8add501930"> Advice for CNB/Immediate surgical intervention</p>
              </td>
            </tr>
            <tr id="table-row-026d52491c5640d4a0e60bcfd85513c9">
              <td id="table-cell-b26812688bea4e139cb01014aa1c4881" align="left">
                <p id="paragraph-4157618e74eb438bae43782ba367126d"> <bold id="strong-1d7e827e186d4836aed578bfd4f1205e">Total</bold></p>
              </td>
              <td id="table-cell-caaa0cfe9f7e4b0f9c3f01e0bf744c23" align="left">
                <p id="paragraph-aee7064868114c64b254786a51fa24fd"> </p>
              </td>
              <td id="table-cell-f16bd89b23bf4282bf672a079b29f7aa" align="left">
                <p id="paragraph-f9864e2d5b7e4d16a499a41b23623616"> 89</p>
              </td>
              <td id="table-cell-bf12c77bd711462588029d44b8336508" align="left">
                <p id="paragraph-0eef5e6c8f7142a7b3bf104443608e69"> </p>
              </td>
              <td id="table-cell-f863df6dbbd4400599e00a683ea6231f" align="left">
                <p id="paragraph-6d9a0c28566a424a8c2e3b55ed987b02"> 89</p>
              </td>
              <td id="table-cell-8aa777abecae46d3a930ff86d6989449" align="left">
                <p id="paragraph-1f544374025a4e34b4d18b76ce15e742"> </p>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn-group>
            <fn id="f-bf4226a80558">
              <p id="p-1cfa9f5ab731">(*Repeat FNA done immediately after ROSE yielded cellular smears based on which the 10 cases categorized as Insufficient could be re-categorized.)</p>
            </fn>
          </fn-group>
        </table-wrap-foot>
      </table-wrap>
      <p id="paragraph-82c65b1a26ec4e53b054fa58d06f1d70"> </p>
      <table-wrap id="table-wrap-855b363c812a4433afe48af6e706de16" orientation="portrait">
        <label>Table 3</label>
        <caption id="caption-1de435c9c1324b3b92a00b72f34fd36c">
          <title id="title-fa491e405f84470c8d1314eb5052f010">
            <bold id="strong-373677fdf3404ed4b093b9d0012e4c6b">Comparison of diagnostic categories between MGG-stained smears, Field-stained smears and Final cytodiagnosis</bold>
          </title>
        </caption>
        <table id="table-5de01c3abc8e45aab70057eb0a6e9841" rules="rows">
          <colgroup>
            <col width="27.75"/>
            <col width="25.29"/>
            <col width="46.959999999999994"/>
          </colgroup>
          <tbody id="table-section-02e2955099824331b227343e54eb5c29">
            <tr id="table-row-5fc5cdac455c40b29db299717a55b6d6">
              <td id="table-cell-edd0c6e325d04b86be9bb520c0265e4b" align="left">
                <p id="paragraph-111dfc8a97374d328e9ac05345dc507d"> <bold id="strong-4696f33024054b8c94b1f3df2e083273">Categorization by ROSE using Field stain </bold></p>
              </td>
              <td id="table-cell-1951489178274d32bc919b11b26f2a24" align="left">
                <p id="paragraph-f4053eb403d24a698e9591ea20a37e85"> <bold id="strong-edd3e664209a470c8bb30b895daeea0b">MGG stained report </bold></p>
              </td>
              <td id="table-cell-176ffd326ea14979b7e12e5ed492ead4" align="left">
                <p id="paragraph-7b8d0ed2649141208db1b66d60c89b6a"> <bold id="strong-a60a2096cb674af881e99381b40adf85">Final Specific Cytodiagnosis</bold></p>
              </td>
            </tr>
            <tr id="table-row-76a83dea74ad44d49d16997d80c93b24">
              <td id="table-cell-1d544de0cabe4d63bdec7cb45acc87e5" align="left">
                <p id="paragraph-82db2d4a56ba4fd18e54523035a33707"> Insufficient (2)</p>
              </td>
              <td id="table-cell-f37fe5b35d484a90af51881e3ef0f0d4" align="left">
                <p id="paragraph-925adf8198304abc997b033d770c1906"> Insufficient (2)</p>
              </td>
              <td id="table-cell-5480c3fd8bed45df888ccb1240884ab8" align="left">
                <p id="paragraph-18289eaa3cb1401483322381805c8838"> -</p>
              </td>
            </tr>
            <tr id="table-row-9f22cb794ad04f29b9fcbe27c21b790d">
              <td id="table-cell-9e272608aad943e3a79f80a5716f8632" align="left">
                <p id="paragraph-b0f945842a5648cf9fad0085909fd03d"> Benign (62)</p>
              </td>
              <td id="table-cell-6efbfd615c2a4684896e44255ec5a191" align="left">
                <p id="paragraph-4496be5160614f88814c51939502168a"> Benign (62)</p>
              </td>
              <td id="table-cell-c1f6e52f28a74daf87185dc493966645" align="left">
                <p id="paragraph-9585ec80464344b1b0eaf81e50cacabf"> Mastitis-4,  Galactocoele-4,  Gynaecomastia-2,  Benign Breast Lesion (BBL) - 12,  Fibroadenoma-40</p>
              </td>
            </tr>
            <tr id="table-row-a7a8747761c04c95a1852200143fa584">
              <td id="table-cell-371fec7a8bcd4573b7ffaadaeaefd8c0" align="left">
                <p id="paragraph-d7bede90e6c9481bba12d8918d9e9152"> Atypical (5)</p>
              </td>
              <td id="table-cell-27c1a90a74724c5d98766a8cda436de7" align="left">
                <p id="paragraph-6eee552e268b494481145a709d57d63a"> Atypical (5)</p>
              </td>
              <td id="table-cell-88cef23b77c64bada67ca49e9dc67252" align="left">
                <p id="paragraph-dec0e0c676bf4856957c717ca6a82f74"> Phyllodes- 2,  Proliferative Breast Disease (PBD)- 3</p>
              </td>
            </tr>
            <tr id="table-row-66862e6374a24310b801c0a51cf52a52">
              <td id="table-cell-bd4b7634056843589f2ff248f9281f56" align="left">
                <p id="paragraph-f937b7a7a9644ae98a3fb89a8c094218"> Suspicious (8)</p>
              </td>
              <td id="table-cell-e8566d68a883442a851edb91c53f69e4" align="left">
                <p id="paragraph-6b6f6e9aff5046739795e7e896afd1ac"> Suspicious (8)</p>
              </td>
              <td id="table-cell-87e1b52a067640ab9b6c328ceefeb62e" align="left">
                <p id="paragraph-c23f0177fed84ecb953e6cbadd9b1e79"> PBD with Atypia-8</p>
              </td>
            </tr>
            <tr id="table-row-92616e4748e24d8c9d53caa156ed69d7">
              <td id="table-cell-e95aeaadff4b4f46bbf13e1794c3bda7" align="left">
                <p id="paragraph-e068d89ffa1543ba9ad65f19abc49fb3"> Malignant (12)</p>
              </td>
              <td id="table-cell-843942df77e64b60a38a8b78f83ff8fb" align="left">
                <p id="paragraph-e972e193797a4c39887e8e2059818057"> Malignant (12)</p>
              </td>
              <td id="table-cell-d3f496e1685744e6a53eeb0c7b6a2b60" align="left">
                <p id="paragraph-9646696904ce41a2a799651f1cb3dada"> Ductal malignancy- 12</p>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p id="paragraph-1cb0fc98a6434c17aeac5af59ba6d150">Categorization of the breast lumps by ROSE using Field stain were in complete agreement with the MGG stained smears and the final FNA diagnosis and showed no discrepancy (Kappa=1 with 95% CI- 1.0 to 1.0). Overall sensitivity of this study was 97.75% (95% CI- 92.12% to 99.73%) while Positive predictive value was 100% (95% CI- 95.85% to 100%).</p>
      <fig id="figure-fca4903d55224eb88bad7f089540e29c" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 1 </label>
        <caption id="caption-c0fe71030654483db1b39e068affcd65">
          <title id="title-77eabc7da9d54b0baf31c502e20f5bfb">
            <bold id="strong-f6e063b6d30947bdbc81b3919e3d24c9">Highly cellular smear comprising benign epithelial cells in clusters, stromal fragments and dispersed bare bipolar nuclei in a clean background (Field stain) 10X</bold>
          </title>
        </caption>
        <graphic id="graphic-4742f33d6713433fb1f4c52661a8f172" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2ea64d57-625e-4e78-a6c2-21b647a27eefimage1.png"/>
      </fig>
      <fig id="figure-6cca07b895a548b1851aca8834d0605c" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 2 </label>
        <caption id="caption-83c94ebbfee647e180f4631497afd46c">
          <title id="title-e7f41010e4b74ec19def1de637f1fcce">
            <bold id="strong-2c967546fab04f8ba552e75e014a6bf8">Duct carcinoma- Large cells with pleomorphic hyperchromatic nuclei and scant to moderate cytoplasm (a- Field, b-MGG 40X) with stromal infiltration and extensive fibrosis (c,d- Field 40X)</bold>
          </title>
        </caption>
        <graphic id="graphic-7fa97536c6654ef3b2ec8adefae91dfd" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2ea64d57-625e-4e78-a6c2-21b647a27eefimage2.png"/>
      </fig>
      <fig id="figure-cee00544cfe54b3fb5196f56d10f3169" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 3 </label>
        <caption id="caption-1d8dfa2015c5485bb2066824ec10345a">
          <title id="title-66066cf5f88b429d93fc238b73c970f2">
            <bold id="strong-abe543ecdb2b42a8bc16befce21ec04e">Elderly male with Duct Carcinoma (a columnar cell change in Field, b-MGG 40X), muscle infiltration and fibrin strands (c,d- Field 40X)</bold>
          </title>
        </caption>
        <graphic id="graphic-6b59d87c42314f578a9c1102b29f9f3f" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2ea64d57-625e-4e78-a6c2-21b647a27eefimage3.png"/>
      </fig>
      <fig id="figure-2ddb2ce314774ceea34de7422ceea57c" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 4 </label>
        <caption id="caption-6cb58ea5485149c0a818f92e5601d8a9">
          <title id="title-c9f7bfe3fd0a488fa2736fca46e76058">
            <bold id="strong-fbfeca160a6747d68c6b59c8d7911337">Duct Carcinoma. Comparable patterns on Field stain smear (crisp cellular morphology) and histopathology. (a- acinar pattern, b- trabecular pattern 40X)</bold>
          </title>
        </caption>
        <graphic id="graphic-734201bdeb9c4419b65c0ec596ada923" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2ea64d57-625e-4e78-a6c2-21b647a27eefimage4.png"/>
      </fig>
    </sec>
    <sec>
      <title id="title-d84f1ac61f634d87812f23992f9c6326">
        <bold id="s-b831be32ce69">DISCUSSION</bold>
      </title>
      <p id="paragraph-fcafd3217310429dbeeeca14c42615f5">FNA is a multistep process, and many factors have the potential to affect the overall diagnostic yield.<sup id="superscript-5f8da95e307a448399f7918971182f32"><xref id="xref-0bf36d984b51431f893668fec084d69d" rid="R271324933257365" ref-type="bibr">11</xref></sup> Role of ROSE has been evaluated for assessing adequacy in various organs especially during advanced aspiration cytology techniques like CT guided FNA, endoscopic ultrasound-guided (EUS), transbronchial aspiration cytology. With the use of ROSE many studies have shown that patients may spend less time in the hospital and require fewer diagnostic procedures and surgical interventions with minimum complications.<sup id="superscript-04c296247f16439aa8c5f60100a89b92"><xref id="xref-b4e79946fb0e481aa299a4e9ed5b5055" rid="R271324933257361" ref-type="bibr">12</xref></sup> ROSE technique also allows for preliminary diagnosis so that additional material can be requested for ancillary studies such as flow cytometry, microbiology cultures, or molecular studies.<sup id="superscript-fe02814074214610a6cbca3df6630126"><xref id="xref-a20924111d8c421aa1e41c50e73e96db" rid="R271324933257366" ref-type="bibr">6</xref></sup> A recent meta-analysis of studies found an overall improvement of 12% in adequacy rates with ROSE but variations may be there according to the initial adequacy rate without ROSE.<sup id="s-e915acd651c3"><xref rid="R271324933257371" ref-type="bibr">13</xref>, <xref rid="R271324933257433" ref-type="bibr">14</xref></sup><bold id="strong-c6a7a1a5ba7e4ba4b9b1c68f395dcbb4"> </bold>A recent study by<bold id="strong-0d29ed2771904f5ebcac0339948c5c17"> </bold>Agrawal N. et al<sup id="s-abd783481ee3"><xref id="xref-fa75207de8214ecbafc6518993c05369" rid="R271324933257368" ref-type="bibr">15</xref></sup> integrated the use of ROSE along with the International Academy of Cytology (IAC) Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology. The observation of the study was that there was improvement in the accuracy of diagnosis of breast lesions, decreased missed diagnoses by reducing number of insufficient cases, improved concordance between cytology and subsequent biopsy reports along with a standardized reproducible system for the monitoring and auditing of breast pathology services and improved training at pathology centers. </p>
      <p id="paragraph-bb72b655591f4ca69398262be0f302df">A wide variety of cytologic stains (such as Haematoxylin and Eosin, Pap and May Grunwald Giemsa stain) are employed for staining of routine FNA smears across different laboratories. The average time required for fixation and staining of the smears varies for different stains, with air-dried smears stained with MGG stain requiring the least time that is around 20 minutes. For ROSE, stains like rapid H&amp;E, ultra-fast PAP, toluidine blue, brilliant cresyl blue (BCB), and Diff-Quik have been used in various research articles.<sup id="superscript-0b508f9f78c844c9968376968feb667c"><xref rid="R271324933257375" ref-type="bibr">16</xref>, <xref rid="R271324933257356" ref-type="bibr">17</xref></sup> Some studies have used toluidine blue but there are disadvantages like high false positivity rate and low specificity in staining dysplasia.<sup id="superscript-93da2f78893c4d0986f3e74142c15b54"><xref id="xref-3addebb35ad7409fb44fe8e72d1783d8" rid="R271324933257362" ref-type="bibr">18</xref></sup></p>
      <p id="paragraph-27f0771875c7468e9ba5af4cb44dc4c3">In the present study ROSE of breast lesions was done using Field’s stain. The main objective of this study was to evaluate the practicability of Field’s stain in ROSE smears. Field stain was chosen because this stain is routinely used for examination of peripheral blood smears in various diagnostic camps held in remote Peripheral Health Care centers besides being cheap and readily available with good staining quality. So, it negates the need to carry any extra reagents or equipment. </p>
      <p id="paragraph-aad5191e45634a45b5a5c9dd740f2b92">It is a water based stain that provides good nucleo-cytoplasmic definition on air-dried alcohol fixed slides. Staining procedure by Field stain is extremely fast which takes less than a minute to be completed. Immediate screening of the smear can be done, and if the smears are found to be insufficient, repeat FNA can be performed immediately. Another advantage of using Field stain in ROSE is that the slide can be examined without mounting with DPX which further reduces time and expenditure. So, the overall turnaround time is rapid while being cost effective. To the best of our knowledge, none of the previous research articles have used this readily available and affordable Field stain in ROSE. Detailed cell morphology, arrangement of cells, stromal and muscle infiltration, and fibrosis if any can be very well appreciated in smears stained with Field stain. This was the major reason for total concordance of results between Field stain and MGG stain. And in few cases the cell arrangements observed on smears stained with Field stain were comparable to the subsequent histopathology sections. </p>
      <p id="paragraph-a3b7ab2005494cdcb0e3bc5cb972c7bb">Mean age in our study was 32.93 years which is comparable with studies done by Kanchan Kothari et.al.<sup id="s-7fab238e75b9"><xref id="xref-1ebcadf5ee4f4af8bf1eec0a8384f825" rid="R271324933257370" ref-type="bibr">19</xref></sup> and Asteria H. Kimambo et.al.<sup id="superscript-de5fc8f89bad4890a002a3be2d473071"><xref id="xref-3b3edeacf3a74e0f899f9c73fa7e8646" rid="R271324933257363" ref-type="bibr">20</xref></sup> Age range in our study was 15 years to 86 years while it was wider in range in study done by Kanchan et.al.<sup id="s-c56c1092a67a"><xref id="xref-55c5575fd925458da6c5fb7cf2618a74" rid="R271324933257370" ref-type="bibr">19</xref></sup> and in concordance with study done by Asteria H. Kimambo et.al. (18 to 75 years)<sup id="superscript-ada92713bb9d4c008f59a2ebdad63fc0"><xref id="xref-83c4bf7c6a38451981a75c26126b7f2a" rid="R271324933257363" ref-type="bibr">20</xref></sup> and Yadav et.al. (18 years to 74 years)<sup id="superscript-88eb28da568d41d5ba4d85ed17779864"><xref id="x-ec669638498d" rid="R271324933257440" ref-type="bibr">21</xref></sup>. Most of the patients in our study were females (86 of 89, 96.6%) as it was in the study by Asteria H. Kimambo et.al (48 of 50, 96%). <sup id="superscript-73f9c35d68d3422aa3e83aef5e8b578a"><xref id="xref-949ce824eb0d4ac09860c17a6630f7ff" rid="R271324933257363" ref-type="bibr">20</xref></sup> </p>
      <p id="paragraph-da82829c29394808b056f5aabf3fffa8">In the present study, the adequacy rate obtained after first aspiration was 84.2% which increased to 97.7% after repeat aspiration was done in those cases that were categorized as insufficient after ROSE with the use of Field stain. The increase in adequacy has also been reported in other studies<sup id="superscript-d5bd7df7cb504b09ae4d6e3fc81d6c1d"><xref id="xref-c339969731e24f76816891958ca80da7" rid="R271324933257364" ref-type="bibr">1</xref></sup>. In the study by Asteria H. Kimambo et.al<xref id="xref-71e50574bfb7482386e26b9e424ffdc5" rid="R271324933257363" ref-type="bibr">20</xref> among preliminary diagnoses 92% cases were benign while 8% cases were malignant and after final cytologic review 76% cases were benign and 20% cases were malignant. No difference was observed in the present study between preliminary diagnoses using Field stain and the final FNA diagnosis using MGG stain and also in terms of cell morphology, stroma, background staining and other features. In the present study, the maximum number of cases was benign (69.6%) who were reassured in the first visit itself and further management could be planned as per the patient’s convenience. In 4 cases FNA proved to be therapeutic as it yielded milky aspirate, and the lumps regressed completely after aspiration. In these 4 cases, though the smears showed scant cellularity, lipo proteinaceous material was observed in the background with few foamy cells. Correlating the cytological features with history of lactation and with the ultrasound findings, these cases were categorized as Benign and interpreted as Galactocoele and repeat FNA was not required. 13.4% cases were categorized as malignant who were advised immediate surgical consultation that helped decrease the time period between final FNA report and further surgical management. The cases (14.5%) in the atypical and suspicious categories had to wait for the final FNA report but were informed about the provisional diagnosis and further possible management after ROSE. However, it was observed that there was total correlation of the provisional diagnoses and final diagnoses in all cases included in these two categories. Hence in these cases also ROSE with Field staining of smears can be used for prompt reports. </p>
      <p id="paragraph-34056fd3fb554591a6a9f832e232f516">Sensitivity of this study was 97.75% with Positive predictive value of 100%. There was a very low false negative rate (2.24%) with no false positivity. This was in concordance with studies done by Kanchan et.al.<sup id="superscript-13500980c9454c2482b35312037e611d"><xref id="xref-80559f037ba74d6cb96c4772e21b9bc6" rid="R271324933257370" ref-type="bibr">19</xref></sup> and Joy et.al.<sup id="superscript-e6c0c5a68e4b4c8491bea9f1ee6aa64c"><xref id="xref-ec83fa31804c4e568953968423589262" rid="R271324933257369" ref-type="bibr">2</xref></sup></p>
      <p id="paragraph-243b5daab3ff47048ee56a87f36fa27c">Breast lesions were included in this study as these are the most common lesions encountered in the cytology OPD of the Tertiary Care Center where this study was conducted. The incidence rate of breast cancer is increasing in relatively younger age groups (25-49 years) with an incidence of 32.89%.<sup id="superscript-63c3079a5e4948e18d2882e8496c93e4"><xref id="xref-b4875a85901244f2a089f90f60106ae0" rid="R271324933257374" ref-type="bibr">22</xref></sup> Though radiologic screening procedures like mammography are readily available in India, they are not easily accessible and affordable to patients in peripheral regions and in remote areas. Core Needle Biopsies too are best done under guidance at higher centers, and specifically in those cases where Duct Carcinoma is suspected. FNA of breast lumps is an established technique for diagnosing palpable breast lesions which is safe, effective, economical, and accurate. FNA along with staining of smears with Field stain and ROSE can prove to be invaluable as a screening technique in Peripheral Health Care centers and in diagnostic camps held in remote areas. The advantages of using Field stain for ROSE as already stated are that evaluation of breast lumps or any other lesion can be done in a diagnostic camp at a remote center with no added financial burden and can be completed rapidly so that the patient can be issued a preliminary report within a few minutes. And most importantly it can help in the triage of patients into those who require immediate surgical referral to tertiary health care centers as against those who can plan their visit for a later date. This holds significance considering the underprivileged section of society living in remote areas that do not have easy and ready access to higher health care centers. </p>
    </sec>
    <sec>
      <title id="title-60f1cdaed14b4b598b131270000f6a4d">CONCLUSION</title>
      <p id="paragraph-1b7396c79a6c4c44aa30cf143c6b3291">ROSE using Field stain is a quick and easy method in making provisional diagnosis in patients with breast lumps. In the present study it was observed that using Field stain for ROSE had comparable staining quality to MGG which resulted in accurate correlation between provisional and final diagnoses. Field stain is readily available and commonly used in diagnostic camps In Indian rural settings and hence can be easily used for screening breast or any other superficial lump patients in health camps without any added burden on budget. In government hospitals the majority of patients are poor who cannot afford multiple visits to higher centers. So, further line of management can be decided immediately in one visit, minimizing delay in diagnosis and repeated visits. Once validated, this would definitely help in patient care in settings where diagnostic services are limited. Thus, ROSE can definitely blossom in Field!.</p>
    </sec>
    <sec>
      <title id="t-a173fa05bf48">Disclosure</title>
      <p id="p-2977fc51f810"><bold id="s-d328d9592a58">Funding: </bold>None</p>
      <p id="p-6e85bfc8c510"><bold id="s-c24b8e13196f">Conflict of Interest: </bold>None Declared</p>
      <p id="p-d216d0a1a863"><bold id="s-d4866123a0b5">Author Contribution:</bold> All the authors involved in study have contributed equally at all stages of work</p>
      <p id="p-bb7a3d9bf078"><bold id="s-d9ee9788320a">Acknowledgements: </bold>I would like to express my appreciation to all those who have supported and contributed to the completion of this project</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R271324933257364">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ammanagi</surname>
              <given-names>A S</given-names>
            </name>
            <name>
              <surname>Dombale</surname>
              <given-names>V D</given-names>
            </name>
            <name>
              <surname>Patil</surname>
              <given-names>Sharada S</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>On-site toluidine blue staining and screening improves efficiency of fine-needle aspiration cytology reporting</article-title>
          <source>Acta Cytologica</source>
          <year>2012</year>
          <volume>56</volume>
          <issue>4</issue>
          <fpage>347</fpage>
          <lpage>351</lpage>
          <uri>https://doi.org/10.1159/000338725</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257369">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joy</surname>
              <given-names> M P</given-names>
            </name>
            <name>
              <surname>Iyer</surname>
              <given-names>Venkateswaran K</given-names>
            </name>
            <name>
              <surname>Aron</surname>
              <given-names>Manju</given-names>
            </name>
            <name>
              <surname>Kapila</surname>
              <given-names>Kusum</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>Kusum</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Rapid staining using toluidine blue: a reliable method for quick diagnosis in ultrasound-guided aspiration cytology</article-title>
          <source>Indian Journal of Pathology &amp; Microbiology</source>
          <year>2003</year>
          <volume>46</volume>
          <issue>4</issue>
          <fpage>589</fpage>
          <lpage>592</lpage>
          <uri>https://pubmed.ncbi.nlm.nih.gov/15025350/</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257373">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bandiera</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arrigoni</surname>
              <given-names>G</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy</article-title>
          <source>Mediastinum</source>
          <year>2020</year>
          <volume>4</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <uri>https://doi.org/10.21037/med-20-28</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257367">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Griffin</surname>
              <given-names>A C</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>Lauren Ende</given-names>
            </name>
            <name>
              <surname>Baloch</surname>
              <given-names>Zubair W</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Utility of on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspiration specimens</article-title>
          <source>Cytojournal</source>
          <year>2011</year>
          <volume>8</volume>
          <fpage>20</fpage>
          <uri>https://doi.org/10.4103/1742-6413.90081</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257360">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suen</surname>
              <given-names>K C</given-names>
            </name>
            <name>
              <surname>Abdul-Karim</surname>
              <given-names>Fadi W</given-names>
            </name>
            <name>
              <surname>Kaminsky</surname>
              <given-names>David B</given-names>
            </name>
            <name>
              <surname>Layfield</surname>
              <given-names>Lester J</given-names>
            </name>
            <name>
              <surname/>
              <given-names>Theodore R Miller</given-names>
            </name>
            <name>
              <surname/>
              <given-names> Susan E Spires</given-names>
            </name>
            <collab/>
            <etal/>
          </person-group>
          <article-title>Guidelines of the Papanicolaou Society of Cytopathology for the Examination of Cytologic Specimens Obtained from the Respiratory Tract</article-title>
          <source>Diagnostic Cytopathology</source>
          <year>1999</year>
          <volume>21</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>69</lpage>
          <uri>https://doi.org/10.1002/(SICI)1097-0339(199907)21:1%3C61::AID-DC17%3E3.0.CO;2-O</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257366">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nasuti</surname>
              <given-names>J F</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>Prabodh K</given-names>
            </name>
            <name>
              <surname>Baloch</surname>
              <given-names>Zubair W</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: Review of 5,688 cases</article-title>
          <source>Diagnostic Cytopathology1</source>
          <year>2002</year>
          <volume>27</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <uri>https://doi.org/10.1002/dc.10065</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257359">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>Gilda da Cunha</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>Hyang-Mi</given-names>
            </name>
            <name>
              <surname>Saieg</surname>
              <given-names>Mauro Ajaj</given-names>
            </name>
            <name>
              <surname>Geddie</surname>
              <given-names>William R</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>‘The Petals and Thorns’’ of ROSE (Rapid On-Site Evaluation)</article-title>
          <source>Cancer Cytopathology</source>
          <year>2013</year>
          <volume>121</volume>
          <issue>1</issue>
          <fpage>4</fpage>
          <lpage>8</lpage>
          <uri>https://doi.org/10.1002/cncy.21215</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257358">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname/>
              <given-names>Franck-A Ekoka Mbassi</given-names>
            </name>
            <name>
              <surname/>
              <given-names>Ghyslain Mombo-Ngoma</given-names>
            </name>
            <name>
              <surname>Ndoumba</surname>
              <given-names>Wilfrid Ndzebe</given-names>
            </name>
            <name>
              <surname>Yovo</surname>
              <given-names>Emmanuel K</given-names>
            </name>
            <name>
              <surname>Eberhardt</surname>
              <given-names>Kirsten A</given-names>
            </name>
            <name>
              <surname>Mbassi</surname>
              <given-names>Dorothea Ekoka</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Performance of Field's Stain Compared with Conventional Giemsa Stain for the Rapid Detection of Blood Microfilariae in Gabon</article-title>
          <source>American Journal of Tropical Medicine and Hygiene</source>
          <year>2022</year>
          <volume>107</volume>
          <issue>2</issue>
          <fpage>383</fpage>
          <lpage>387</lpage>
          <uri>https://doi.org/10.4269/ajtmh.22-0061</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257372">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Chougule</surname>
              <given-names>M</given-names>
            </name>
            <collab/>
          </person-group>
          <person-group person-group-type="editor"/>
          <article-title>Intraoperative Cytology Staining Technique</article-title>
          <source> Neuropathology of Brain Tumors with Radiologic Correlates </source>
          <publisher-name>Springer</publisher-name>
          <publisher-loc>Singapore</publisher-loc>
          <year>2020</year>
          <fpage>361</fpage>
          <uri>https//doi.org/10.1007/978-981-15-7126-8_25</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257357">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Field</surname>
              <given-names>A S</given-names>
            </name>
            <collab/>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname/>
              <given-names>A S Field</given-names>
            </name>
            <name>
              <surname/>
              <given-names>M R Zarka</given-names>
            </name>
          </person-group>
          <article-title>Fine Needle Aspiration Biopsy Cytology of Breast: A Diagnostic Approach Based on Pattern Recognition </article-title>
          <source>Practical Cytopathology: A Diagnostic Approach to Fine Needle Aspiration Biopsy</source>
          <publisher-name>Elsevier</publisher-name>
          <publisher-loc>Amsterdam</publisher-loc>
          <year>2017</year>
          <fpage>147</fpage>
          <lpage>231</lpage>
          <uri>https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781416057697000051</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257365">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>R L</given-names>
            </name>
            <name>
              <surname>Factor</surname>
              <given-names>R E</given-names>
            </name>
            <name>
              <surname>Affolter</surname>
              <given-names>K E</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>J B</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>B J</given-names>
            </name>
            <name>
              <surname>Narra</surname>
              <given-names>K K</given-names>
            </name>
            <collab/>
            <etal/>
          </person-group>
          <article-title>Methods specification for diagnostic test accuracy studies in fine-needle aspiration cytology: a survey of reporting practice</article-title>
          <source>American Journal of Clinical Pathology</source>
          <year>2012</year>
          <volume>137</volume>
          <issue>1</issue>
          <fpage>132</fpage>
          <lpage>141</lpage>
          <uri>https://doi.org/10.1309/ajcpqx1kbj2pzjfk</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257361">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kitagawa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kogure</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Murata</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ando</surname>
              <given-names>M</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Rapid On-Site Cytologic Evaluation during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Diagnosing Lung Cancer: A Randomized Study</article-title>
          <source>Respiration</source>
          <year>2013</year>
          <volume>85</volume>
          <issue>6</issue>
          <fpage>486</fpage>
          <lpage>492</lpage>
          <uri>https://doi.org/10.1159/000346987</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257371">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>R L</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>B S</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Layfield</surname>
              <given-names>L J</given-names>
            </name>
            <name>
              <surname>Adler</surname>
              <given-names>D G</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Rapid on-site evaluation reduces needle passes in endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesions: a risk-benefit analysis</article-title>
          <source>Digestive Diseases and Sciences</source>
          <year>2013</year>
          <volume>58</volume>
          <issue>11</issue>
          <fpage>3280</fpage>
          <lpage>3286</lpage>
          <uri>https://doi.org/10.1007/s10620-013-2750-6</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257433">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>Robert L</given-names>
            </name>
            <name>
              <surname>Witt</surname>
              <given-names>Benjamin L</given-names>
            </name>
            <name>
              <surname>Matynia</surname>
              <given-names>Anna P</given-names>
            </name>
            <name>
              <surname>Barraza</surname>
              <given-names>Gonzalo</given-names>
            </name>
            <name>
              <surname>Layfield</surname>
              <given-names>Lester J</given-names>
            </name>
            <name>
              <surname>Adler</surname>
              <given-names>Douglas G</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Rapid On-Site Evaluation Increases Endoscopic Ultrasound-Guided Fine-Needle Aspiration Adequacy for Pancreatic Lesions</article-title>
          <source>Digestive Diseases and Sciences</source>
          <year>2013</year>
          <volume>58</volume>
          <issue>3</issue>
          <fpage>872</fpage>
          <lpage>882</lpage>
          <issn>0163-2116, 1573-2568</issn>
          <publisher-name>Springer Science and Business Media LLC</publisher-name>
          <uri>https://dx.doi.org/10.1007/s10620-012-2411-1</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257368">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agrawal</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kothari</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tummidi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sood</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Agnihotri</surname>
              <given-names>M</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Fine-Needle Aspiration Biopsy Cytopathology of Breast Lesions Using the International Academy of Cytology Yokohama System and Rapid On-Site Evaluation: A Single-Institute Experience</article-title>
          <source>Acta Cytologica</source>
          <year>2021</year>
          <volume>65</volume>
          <issue>6</issue>
          <fpage>463</fpage>
          <lpage>477</lpage>
          <uri>https://doi.org/10.1159/000518375</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257375">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruth</surname>
              <given-names>S E</given-names>
            </name>
            <name>
              <surname>Malay</surname>
              <given-names>S</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Rapid on-site evaluation of EUS-FNA by Cytopathologist: an experience of a tertiary hospital</article-title>
          <source>Diagnostic Cytopathology</source>
          <year>2013</year>
          <volume>41</volume>
          <issue>12</issue>
          <fpage>1075</fpage>
          <lpage>1080</lpage>
          <uri>https://doi.org/10.1002/dc.23047</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257356">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fahad</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Girgis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sandha</surname>
              <given-names>G S</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Does onsite cytotechnology evaluation improve the accuracy of endoscopic ultrasound-guided fine-needle aspiration biopsy?</article-title>
          <source>Canadian Journal of Gastroenterology and Hepatology</source>
          <year>2009</year>
          <volume>23</volume>
          <issue>1</issue>
          <fpage>26</fpage>
          <lpage>30</lpage>
          <uri>https://doi.org/10.1155/2009/194351</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257362">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lingen</surname>
              <given-names>Mark W</given-names>
            </name>
            <name>
              <surname>Kalmar</surname>
              <given-names>John R</given-names>
            </name>
            <name>
              <surname>Karrison</surname>
              <given-names>Theodore</given-names>
            </name>
            <name>
              <surname>Speight</surname>
              <given-names>Paul M</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Critical evaluation of diagnostic aids for the detection of oral cancer</article-title>
          <source>Oral oncology</source>
          <year>2007</year>
          <volume>44</volume>
          <issue>1</issue>
          <fpage>10</fpage>
          <lpage>22</lpage>
          <uri>https://doi.org/10.1016/j.oraloncology.2007.06.011</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257370">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kothari</surname>
              <given-names>Kanchan</given-names>
            </name>
            <name>
              <surname>Tummidi</surname>
              <given-names>Santosh</given-names>
            </name>
            <name>
              <surname>Agnihotri</surname>
              <given-names>Mona</given-names>
            </name>
            <name>
              <surname>Sathe</surname>
              <given-names>Pragati</given-names>
            </name>
            <name>
              <surname>Naik</surname>
              <given-names>Leena</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>This ‘Rose’ Has no Thorns-Diagnostic Utility of ‘Rapid On-Site Evaluation’ (ROSE) in Fine Needle Aspiration Cytology</article-title>
          <source>Indian Journal of Surgical Oncology</source>
          <year>2019</year>
          <volume>10</volume>
          <issue>4</issue>
          <fpage>688</fpage>
          <lpage>698</lpage>
          <uri>https://doi.org/10.1007/s13193-019-00981-y</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257363">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kimambo</surname>
              <given-names>Asteria H</given-names>
            </name>
            <name>
              <surname>Vuhahula</surname>
              <given-names>Edda A</given-names>
            </name>
            <name>
              <surname>Philipo</surname>
              <given-names>Godfrey S</given-names>
            </name>
            <name>
              <surname>Mushi</surname>
              <given-names>Beatrice P</given-names>
            </name>
            <name>
              <surname>Mmbaga</surname>
              <given-names>Elia J</given-names>
            </name>
            <name>
              <surname/>
              <given-names> Katherine Van Loon</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names> Dianna L</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Rapid Onsite Evaluation for Specimen Adequacy and Triage of Breast Masses in a Low-Resource Setting</article-title>
          <source>Archives of Pathology &amp; Laboratory Medicine</source>
          <year>2024</year>
          <volume>148</volume>
          <issue>1</issue>
          <fpage>9</fpage>
          <lpage>17</lpage>
          <uri>https://doi.org/10.5858/arpa.2022-0398-oa</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257440">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yadav</surname>
              <given-names>Ranjan</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>Nikita</given-names>
            </name>
            <name>
              <surname>Bakna</surname>
              <given-names>Minu</given-names>
            </name>
            <name>
              <surname>Bhadkariya</surname>
              <given-names>Anand</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>Arjun</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Cytomorphological spectrum of breast fine needle aspiration cytology using the International Academy of Cytology Yokohama System and evaluation of associated risk of malignancy–A retrospective study in a tertiary care cente</article-title>
          <source>Surgical and Experimental Pathology</source>
          <year>2024</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <issn>2520-8454</issn>
          <publisher-name>Springer Science and Business Media LLC</publisher-name>
          <uri>https://dx.doi.org/10.1186/s42047-024-00148-2</uri>
        </element-citation>
      </ref>
      <ref id="R271324933257374">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillai</surname>
              <given-names>R N</given-names>
            </name>
            <name>
              <surname>Alex</surname>
              <given-names>Aleena</given-names>
            </name>
            <name>
              <surname/>
              <given-names>M S Narassima</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>Vivek</given-names>
            </name>
            <name>
              <surname>Shaji</surname>
              <given-names>Ajil</given-names>
            </name>
            <name>
              <surname>Pavithran</surname>
              <given-names>Keechilat</given-names>
            </name>
            <collab/>
            <etal/>
          </person-group>
          <article-title>Economic burden of breast cancer in India, 2000-2021 and forecast to 2030</article-title>
          <source>Scientific Reports</source>
          <year>2025</year>
          <volume>15</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <uri>https://doi.org/10.1038/s41598-024-83896-1</uri>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
